Physician profile
Amit K Mathur
NPI 1891814034
$17,568.20
in general payments reported to CMS, 2019-2025
10 companies · $1,670 in 2025
The $1,670 reported for 2025 was more than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,606 · 2020: $11.05 · 2021: $5,043 · 2022: $1,416 · 2023: $2,009 · 2024: $5,813 · 2025: $1,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,523 · Consulting Fee: $2,685 · Food and Beverage: $1,258 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,523.14 |
| Consulting Fee | $2,685.00 |
| Food and Beverage | $1,257.93 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Transmedics, INC. | $8,729.12 | 2021-2025 | Organ Care System |
| Intuitive Surgical, INC. | $3,245.56 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,733.43 | 2023-2024 | Imfinzi |
| Genentech USA, INC. | $1,606.36 | 2019 | |
| Paragonix Technologies, INC. | $513.74 | 2024 | Liverguard, Sherpapak, Pancreaspak |
| Dilon Technologies, INC. | $289.18 | 2024-2025 | Hemoblast Bellows |
| Boston Scientific Corporation | $155.38 | 2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Medtronic, INC. | $144.73 | 2023-2025 | Invos, Signia |
| Baxter Healthcare | $125.00 | 2022 | |
| Merck Sharp & Dohme LLC | $25.70 | 2025 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Mathur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.